Your browser doesn't support javascript.
loading
Eph receptors as cancer targets for antibody-based therapy.
Tang, Fenny H F; Davis, Deodate; Arap, Wadih; Pasqualini, Renata; Staquicini, Fernanda I.
Affiliation
  • Tang FHF; Rutgers Cancer Institute of New Jersey, Newark, NJ, United States; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, United States.
  • Davis D; Rutgers Cancer Institute of New Jersey, Newark, NJ, United States; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, United States.
  • Arap W; Rutgers Cancer Institute of New Jersey, Newark, NJ, United States; Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, United States. Electronic address: wadih.arap@rutgers.edu.
  • Pasqualini R; Rutgers Cancer Institute of New Jersey, Newark, NJ, United States; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, United States. Electronic address: renata.pasqualini@rutgers.edu.
  • Staquicini FI; Rutgers Cancer Institute of New Jersey, Newark, NJ, United States; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, United States. Electronic address: fernanda.staquicini@rutgers.edu.
Adv Cancer Res ; 147: 303-317, 2020.
Article in En | MEDLINE | ID: mdl-32593404
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Eph Family / Antibodies, Monoclonal / Neoplasms Type of study: Guideline Limits: Animals / Humans Language: En Journal: Adv Cancer Res Year: 2020 Type: Article Affiliation country: United States
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Receptors, Eph Family / Antibodies, Monoclonal / Neoplasms Type of study: Guideline Limits: Animals / Humans Language: En Journal: Adv Cancer Res Year: 2020 Type: Article Affiliation country: United States